Compare 10X Genomics Inc (TXG) vs Vanguard Short Term Corporate Bond ETF (VCSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
10X Genomics Inc vs Vanguard Short Term Corporate Bond ETF — how do they compare? 10X Genomics Inc trades at $59 (market cap $7.61B), while Vanguard Short Term Corporate Bond ETF trades at $78.52. The key difference: 10X Genomics Inc is trading nearer its 52-week high, Vanguard Short Term Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.
| TXG | VCSH | |
|---|---|---|
Market Cap | $7.61B | — |
Sector | Health | Fixed Income |
52-Week High | $58.57 | $80.20 |
52-Week Low | $11.34 | $78.41 |
Enterprise Value | $7.14B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →About Vanguard Short Term Corporate Bond ETF
VCSH tracks the Bloomberg U.S. 1-5 Year Corporate Bond Index, focusing on high-quality, investment-grade debt with short maturities. It is designed to offer higher income than Treasury bills with significantly lower interest rate sensitivity than intermediate or long-term bond funds.
Read more on VCSH →
